ORCHA is the Organisation for the Review of Care and Health Apps, positioning itself as a major player in the digital health market. With healthcare undergoing a digital revolution, ORCHA addresses the concern of unregulated digital health products, with 80% failing to meet standards. The company boasts an impressive track record, having reviewed a higher number of digital health products than any other entity globally. ORCHA's agile technology sets it apart, enabling the review and certification of digital health technology at a remarkable speed, 5,000x faster than any competitor. This pace allows for the provision of a comprehensive digital health library, currently holding 9,000 assessed products. Notable clients such as Public Health England, MHRA, NHS Digital, Mental Health Commission of Canada, and the American Telemedicine Association testify to ORCHA's credibility and impact. The company's recent accolades further validate its standing within the industry. Notably, ORCHA received the NHS Supplier Partnership of the Year for 2022 at the HTN Forward Healthcare Awards, solidifying its reputation as an outstanding collaborator, as recognized by the HETT Awards. In addition, the company was acknowledged with the Innovative eHealth Solution award at the 2022 WITSA Global Innovation Awards, and was a runner-up for the Health Tech Innovation of the Year at the 2022 Digital Leaders 100. ORCHA’s inclusion in the Inaugural Top 50 Women in Leadership list for 2022 by Deloitte Tech Fast 50 adds to its growing list of accomplishments. Founded in 2015 and based in the United Kingdom, ORCHA's growth journey began with a Seed Round investment on 01 January 2016, with William Currie Group coming on board as the investor. Emphasizing the critical need for trusted digital health technologies, ORCHA's impactful presence and rapid growth make it a compelling investment opportunity in the dynamic health and wellness industries.
No recent news or press coverage available for ORCHA.